WAT
Price
$302.95
Change
+$4.48 (+1.50%)
Updated
Jul 25 closing price
Capitalization
20.38B
9 days until earnings call
XYLO
Price
$5.09
Change
-$0.09 (-1.74%)
Updated
Jul 25 closing price
Capitalization
5.21M
Interact to see
Advertisement

WAT vs XYLO

Header iconWAT vs XYLO Comparison
Open Charts WAT vs XYLOBanner chart's image
Waters
Price$302.95
Change+$4.48 (+1.50%)
Volume$1.04M
Capitalization20.38B
Xylo Technologies
Price$5.09
Change-$0.09 (-1.74%)
Volume$1.19K
Capitalization5.21M
WAT vs XYLO Comparison Chart in %
Loading...
WAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XYLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
WAT vs. XYLO commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is WAT is a StrongBuy and XYLO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (WAT: $302.95 vs. XYLO: $5.09)
Brand notoriety: WAT and XYLO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: WAT: 143% vs. XYLO: 25%
Market capitalization -- WAT: $20.38B vs. XYLO: $5.21M
WAT [@Medical Specialties] is valued at $20.38B. XYLO’s [@Medical Specialties] market capitalization is $5.21M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

WAT’s FA Score shows that 1 FA rating(s) are green whileXYLO’s FA Score has 1 green FA rating(s).

  • WAT’s FA Score: 1 green, 4 red.
  • XYLO’s FA Score: 1 green, 4 red.
According to our system of comparison, both WAT and XYLO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

WAT’s TA Score shows that 4 TA indicator(s) are bullish while XYLO’s TA Score has 5 bullish TA indicator(s).

  • WAT’s TA Score: 4 bullish, 6 bearish.
  • XYLO’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, XYLO is a better buy in the short-term than WAT.

Price Growth

WAT (@Medical Specialties) experienced а +5.36% price change this week, while XYLO (@Medical Specialties) price change was -1.42% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.05%. For the same industry, the average monthly price growth was +4.97%, and the average quarterly price growth was -2.20%.

Reported Earning Dates

WAT is expected to report earnings on Nov 04, 2025.

XYLO is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Medical Specialties (+3.05% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WAT($20.4B) has a higher market cap than XYLO($5.21M). WAT has higher P/E ratio than XYLO: WAT (31.78) vs XYLO (2.68). XYLO YTD gains are higher at: 40.608 vs. WAT (-18.338). WAT has higher annual earnings (EBITDA): 1B vs. XYLO (-7.88M). WAT has more cash in the bank: 396M vs. XYLO (27.3M). XYLO has less debt than WAT: XYLO (1.62M) vs WAT (2.44B). WAT has higher revenues than XYLO: WAT (2.96B) vs XYLO (10.1M).
WATXYLOWAT / XYLO
Capitalization20.4B5.21M391,555%
EBITDA1B-7.88M-12,709%
Gain YTD-18.33840.608-45%
P/E Ratio31.782.681,186%
Revenue2.96B10.1M29,267%
Total Cash396M27.3M1,451%
Total Debt2.44B1.62M151,114%
FUNDAMENTALS RATINGS
WAT vs XYLO: Fundamental Ratings
WAT
XYLO
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
1
Undervalued
PROFIT vs RISK RATING
1..100
55100
SMR RATING
1..100
2397
PRICE GROWTH RATING
1..100
6453
P/E GROWTH RATING
1..100
6852
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XYLO's Valuation (1) in the Medical Specialties industry is significantly better than the same rating for WAT (87). This means that XYLO’s stock grew significantly faster than WAT’s over the last 12 months.

WAT's Profit vs Risk Rating (55) in the Medical Specialties industry is somewhat better than the same rating for XYLO (100). This means that WAT’s stock grew somewhat faster than XYLO’s over the last 12 months.

WAT's SMR Rating (23) in the Medical Specialties industry is significantly better than the same rating for XYLO (97). This means that WAT’s stock grew significantly faster than XYLO’s over the last 12 months.

XYLO's Price Growth Rating (53) in the Medical Specialties industry is in the same range as WAT (64). This means that XYLO’s stock grew similarly to WAT’s over the last 12 months.

XYLO's P/E Growth Rating (52) in the Medical Specialties industry is in the same range as WAT (68). This means that XYLO’s stock grew similarly to WAT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
WATXYLO
RSI
ODDS (%)
Bullish Trend 1 day ago
72%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
62%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
63%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bearish Trend 1 day ago
57%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
63%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 1 day ago
67%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
60%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
75%
Aroon
ODDS (%)
Bearish Trend 1 day ago
56%
Bearish Trend 5 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
WAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XYLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAOI27.131.29
+4.99%
Applied Optoelectronics
AGIO40.000.35
+0.88%
Agios Pharmaceuticals
MORN278.03-0.32
-0.11%
Morningstar
GLTO3.75-0.05
-1.37%
Galecto Inc
HGBL2.15-0.04
-1.83%
Heritage Global

WAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, WAT has been closely correlated with A. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if WAT jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WAT
1D Price
Change %
WAT100%
+1.50%
A - WAT
79%
Closely correlated
-0.14%
MTD - WAT
75%
Closely correlated
+0.26%
RVTY - WAT
68%
Closely correlated
+1.67%
TMO - WAT
64%
Loosely correlated
+0.69%
BRKR - WAT
63%
Loosely correlated
+3.68%
More

XYLO and

Correlation & Price change

A.I.dvisor tells us that XYLO and EXAS have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XYLO and EXAS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XYLO
1D Price
Change %
XYLO100%
-1.64%
EXAS - XYLO
23%
Poorly correlated
-0.57%
VVOS - XYLO
23%
Poorly correlated
-3.32%
WAT - XYLO
23%
Poorly correlated
+1.50%
AZTA - XYLO
23%
Poorly correlated
+1.38%
XGN - XYLO
22%
Poorly correlated
+0.69%
More